Whitepaper: Unique solutions for drug discovery and development
Looking for solutions to resolve your unique challenges? We offer several customized products and services to move your discovery forward.
List view / Grid view
Looking for solutions to resolve your unique challenges? We offer several customized products and services to move your discovery forward.
1 November 2022 | By Standard BioTools
Watch our on-demand webinar to hear about advances toward precision medicine through the use of cutting-edge methods and analysing critical patient immune data in response to therapies and disease progression.
Anti-inflammatory effects of niclosamide, observed in a new pre-clinical study, were due to inhibition of the inflammasome, a protein complex presented in the interior of defence cells.
Compendium of iQue® advanced flow cytometry platform application posters: Antibody discovery and immuno-oncology.
This ebook explores the role of binding kinetics in drug discovery, current methods for kinetic parameter analysis, novel approaches and applications.
Using screening techniques, researchers have identified the compound called AN15368 which works as an antiparasitic against Chagas disease.
Trust in your results — Experience the benefits of iQue® advanced flow cytometry.
7 September 2022 | By Sartorius
Watch this webinar to hear from Dr Yuansheng Yang as he introduces a CHO cell-based technology allowing simultaneous display and secretion of antibodies for accelerating the process of antibody development.
Application note: Quantifying T Cell response in 3D tumour spheroids using advanced flow cytometry workflows.
This publications review overviews advanced flow cytometry applications in infectious disease and immuno-oncology.
This guide highlights the four major stages of TPD, the challenges at each step and questions you should ask yourself.
This whitepaper overviews how high throughput, multi-parametric analysis accelerates antibody discovery workflows.
Researchers from the US have identified several new small molecules that can induce mitophagy in leukaemia cells.
Here Bio-Rad presents the generation of specific anti-CAR T-cell antibodies to show how CAR T-cell analysis benefits from our modular antibody assembly technology using SpyTag-SpyCatcher protein ligation.
9 May 2022 | By PerkinElmer and C4
Looking for a way to address the undruggable proteins in the human body? Watch this free on-demand webinar where industry experts discuss strategies to accelerate TPD drug discovery efforts using high-throughput cell-based assays.